BioGotec focuses primarily on supporting companies with niche, high value products to strategically evaluate all options for setting up commercial operations to supply patients in Europe and then can follow on, if required, to strategically and tactically plan and implement the launches to result in market entry of products quickly, cost-effectively and successfully.The team utilises their past experience and collective expertise to accommodate the resources of their customers resulting in "fit for purpose" planning. Whether it is an Orphan Drug, a product for a rare disease, a new formulation or a novel device our aim is to become the recognised start-up specialists for small pharma and device companies planning their entry to Europe